Novo Nordisk (NVO) Reports Q1 EPS of DKK5.68; updates guidance

Novo Nordisk (NYSE: NVO) reported Q1 EPS of DKK5.68. Revenue for the quarter came in at DKK65.35 billion.

GUIDANCE

For the 2024 outlook, sales growth is now expected to be 19-27% at CER, and operating profit growth is now expected to be 22-30% at CER. Growth reported in Danish kroner is now expected to be in line with CER growth for both sales and operating profit.

For earnings history and earnings-related data on Novo Nordisk (NVO) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Morgan Stanley Starts Adani Enterprises Ltd. (ADE:IN) at Overweight
• Ares Management, L.P. (ARES) PT Raised to $153 at TD Cowen